Indeed, increased peripheral blood eosinophils and eosinophil infiltration into murine breast carcinoma tumors was shown to be correlated with improved response to anti-CTLA4 therapy, as well as vessel normalization (7), suggesting a potential indirect anti-tumorigenic role for eosinophils in the tumor microenvironment. The gene discussed is CTLA4; the disease is breast carcinoma.